Tags

Type your tag names separated by a space and hit enter

[Indicator analysis of prostate cancer centers certified by the German Cancer Society 2015].
Urologe A. 2015 Nov; 54(11):1530, 1532-6.U

Abstract

BACKGROUND

Since the first prostate cancer center was certified by the German Cancer Society (DKG) in 2008, there are currently 94 centers at 95 sites. During certification, data on the implementation of the requirements are collected. These data can be used for benchmarking purposes.

OBJECTIVES

This paper describes the development and monitoring of indicators and presents a selection of recent results.

MATERIALS AND METHODS

The descriptive results on 18,288 primary cases from 91 sites with complete data are presented.

RESULTS

The prostate cancer center certification system has reached a plateau both in regard to the absolute number of centers and the total proportion of all primary cases treated in Germany. The implementation of the requirements is at a high level overall, although some centers have difficulties fulfilling selected key figures, e.g., the study quota requirement.

CONCLUSION

The evaluation of current indicators documented good structural and process quality, which correspond for the most part to the target values for the total cohort. In the future, assessing medium and long-term outcome quality will be of greater importance, particularly with regard to patient-reported outcomes.

Authors+Show Affiliations

Urologische Klinik, Johanniter Krankenhaus Oberhausen, Steinbrinkstraβe 96A, 46145, Oberhausen, Deutschland. Jan.Fichtner@evkln.de.Deutsche Krebsgesellschaft, Berlin, Deutschland.Deutsche Krebsgesellschaft, Berlin, Deutschland.Urologische Universitätsklinik Düsseldorf, Düsseldorf, Deutschland.

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

26573670

Citation

Fichtner, J, et al. "[Indicator Analysis of Prostate Cancer Centers Certified By the German Cancer Society 2015]." Der Urologe. Ausg. A, vol. 54, no. 11, 2015, pp. 1530, 1532-6.
Fichtner J, Kowalski C, Wesselmann S, et al. [Indicator analysis of prostate cancer centers certified by the German Cancer Society 2015]. Urologe A. 2015;54(11):1530, 1532-6.
Fichtner, J., Kowalski, C., Wesselmann, S., & Albers, P. (2015). [Indicator analysis of prostate cancer centers certified by the German Cancer Society 2015]. Der Urologe. Ausg. A, 54(11), 1530, 1532-6. https://doi.org/10.1007/s00120-015-3855-7
Fichtner J, et al. [Indicator Analysis of Prostate Cancer Centers Certified By the German Cancer Society 2015]. Urologe A. 2015;54(11):1530, 1532-6. PubMed PMID: 26573670.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Indicator analysis of prostate cancer centers certified by the German Cancer Society 2015]. AU - Fichtner,J, AU - Kowalski,C, AU - Wesselmann,S, AU - Albers,P, PY - 2015/11/18/entrez PY - 2015/11/18/pubmed PY - 2016/9/1/medline KW - Benchmarking KW - Certification KW - Patient reported outcomes KW - Quality of care KW - Tumordokumentationssystem SP - 1530, 1532-6 JF - Der Urologe. Ausg. A JO - Urologe A VL - 54 IS - 11 N2 - BACKGROUND: Since the first prostate cancer center was certified by the German Cancer Society (DKG) in 2008, there are currently 94 centers at 95 sites. During certification, data on the implementation of the requirements are collected. These data can be used for benchmarking purposes. OBJECTIVES: This paper describes the development and monitoring of indicators and presents a selection of recent results. MATERIALS AND METHODS: The descriptive results on 18,288 primary cases from 91 sites with complete data are presented. RESULTS: The prostate cancer center certification system has reached a plateau both in regard to the absolute number of centers and the total proportion of all primary cases treated in Germany. The implementation of the requirements is at a high level overall, although some centers have difficulties fulfilling selected key figures, e.g., the study quota requirement. CONCLUSION: The evaluation of current indicators documented good structural and process quality, which correspond for the most part to the target values for the total cohort. In the future, assessing medium and long-term outcome quality will be of greater importance, particularly with regard to patient-reported outcomes. SN - 1433-0563 UR - https://www.unboundmedicine.com/medline/citation/26573670/[Indicator_analysis_of_prostate_cancer_centers_certified_by_the_German_Cancer_Society_2015]_ L2 - https://dx.doi.org/10.1007/s00120-015-3855-7 DB - PRIME DP - Unbound Medicine ER -